Lactulose-Any Clinical Benefits beyond Constipation Relief? A Pilot Study in Infants with Allergic Symptoms
2003 年 22 巻 4 号 p. 155-157
詳細
2003 年 22 巻 4 号 p. 155-157
Lactulose has been shown to modify the gut microbiota in increasing bifidobacteria and reducing the numbers of clostridia. In this pilot study we investigated whether the microbiota could be modified in infants with atopic manifestations with or without gastrointestinal symptoms. We could safely promote the bifidobacterial microbiota in symptomatic infants by feeding a low dose of lactulose. The symptoms of the children were concomitantly improved.
